Secondary prophylaxis with low molecular weight heparin: the dose?
Horne
M K
MK
D000074:Acenocoumarol / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D016527:Drug Costs; D017984:Enoxaparin / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000191:economics; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D017762:Nadroparin / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D012008:Recurrence; D020246:Venous Thrombosis / Q000191:economics / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage
D000925:Anticoagulants; D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight; D017762:Nadroparin; D014859:Warfarin; D006493:Heparin; D000074:Acenocoumarol